Saturna Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,350
Closed -$204K 164
2022
Q3
$204K Sell
1,350
-130
-9% -$19.6K 0.01% 150
2022
Q2
$216K Sell
1,480
-270
-15% -$39.4K 0.01% 149
2022
Q1
$207K Sell
1,750
-330
-16% -$39K ﹤0.01% 163
2021
Q4
$287K Buy
2,080
+40
+2% +$5.52K 0.01% 154
2021
Q3
$283K Buy
+2,040
New +$283K 0.01% 157